Immunoprecipitation Market Share, Company Profiles, Launches, & Forecast Till 2028

commentaires · 58 Vues

Technological advancements in immunoprecipitation techniques and increasing deployment in treatment of cancer and cardiovascular diseases expected to bolster market growth

The ‘Global Immunoprecipitation Market’ Report recently published by Reports and Data provides a comprehensive overview of the Immunoprecipitation market with regards to market share, market size, revenue share, revenue contribution, financial developments, macro- and micro-economic factors, and overall industry outlook. The report includes beneficial insights about the market dynamics, profit margins, market share, gross revenue, and other fundamental segments of the market for the forecast period of 2021-2028. Furthermore, the report also discusses the business strategies undertaken by the companies to gain the market share and a larger consumer base and offers strategic recommendations to established companies and new entrants.

The key players of the global immunoprecipitation market are Thermo Fisher Scientific, Abbkine Scientific Co. Ltd., Merck KGaA, Bio-Rad Laboratories, BioLegend, Cell Signaling Technology, Abcam, GenScript Biotech Corporation, Rockland Immunochemicals, Geno Technology, and Takara Bio.

Get a Free Sample Now@

Some Key Highlights From the Report:

  • Based on product type, the reagents segment accounted for largest revenue share in the global immunoprecipitation market in 2020. Increasing use of antibodies, buffers, and beads for immunoprecipitation procedures, escalating demand for advanced IP assays for antigen isolation and purification, and increasing usage of agarose and magnetic beads in protein purification are some of the key factors expected to continue to drive revenue growth of this segment.
  • Academic research institutes segment accounted for substantially large revenue share in 2020, and this trend is expected to continue over the forecast period. Robust growth of this segment is attributed to increasing research and development activities in the fields of molecular biology and genomics, growing research collaborations among global academic institutions, and considerable government investments in academic RD programs.
  • North America market accounted for largest revenue share in 2020, owing to surging government investments in RD activities in the life sciences industry, increasing research collaborations between pharmaceutical companies and academic institutions, and rising number of COVID-19 infections and deaths in countries in the region. The Asia Pacific immunoprecipitation market is expected to register highest revenue CAGR over the forecast period. Steady growth of the market in the region is attributed to increased government investments in pharmaceutical and biotechnological RD activities, rising adoption of personalized medicine, and availability of state-of-the-art healthcare infrastructure in the region.

For the purpose of this report, the global immunoprecipitation market is segmented based on type, product type, end-use, and region:

By Type (Revenue, USD Million; 2018-2028)

  • Individual protein immunoprecipitation
  • Chromatin Immunoprecipitation (ChIP)
  • Co-immunoprecipitation (Co-IP)
  • RNA Immunoprecipitation (RIP)
  • Others

By Product Type (Revenue, USD Million; 2018-2028)

  • Kits
  • Accessories
  • Reagents
  • Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • Beads
  • Agarose Beads
  • Magnetic Beads
  • Buffers

By End-use (Revenue, USD Million; 2018-2028)

  • Pharmaceutical and Biopharmaceutical Companies
  • Academic Research Institutes
  • Contract Research Organizations (CROs)
  • Others

Ask for discount@ 

Regional Outlook (Revenue in USD Million; 2016–2026)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Benelux
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East Africa
    • Israel
    • Egypt
    • Saudi Arabia
    • South Africa
    • Rest of MEA
  • Latin America
    • Brazil
    • Rest of LATAM

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope Premise

    1.3. Methodology

    1.4. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2018 – 2026

Chapter 3. Indicative Metrics

Chapter 4. Immunoprecipitation Segmentation Impact Analysis

    4.1. Immunoprecipitation Segmentation Analysis

    4.2. Immunoprecipitation Market Value Chain Analysis, 2016-2026

    4.3. Regulatory framework

    4.4. Immunoprecipitation Market Impact Analysis

          4.4.1. Market driver analysis


Enquire for customization in Report @

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.